ABSTRACT
Determining how best to allocate resources to be used during a pandemic is a strategic decision that directly affects the success of pandemic response operations. However, government agencies have finite resources, so they can’t monitor everything all of the time: they have to decide how best to allocate their scarce resources (i.e., budget for antivirals and preventive vaccinations, Intensive Care Unit (ICU), ventilators, non-intensive Care Unit (non-ICU), doctors) across a broad range of risk exposures (i.e., geographic spread, routes of transmission, overall poverty, medical preconditions). This paper establishes a comprehensive risk-based emergency management framework that could be used by decision-makers to determine how best to manage medical resources, as well as suggest patient allocation among hospitals and alternative healthcare facilities. A set of risk indexes are proposed by modeling the randomness and uncertainty of allocating resources in a pandemic. The city understudy is modeled as a Euclidean complex network, where depending on the neighborhood influence of allocating a resource in a demand point (i.e., informing citizens, limit social contact, allocate a new hospital) different network configurations are proposed. Finally, a multi-objective risk-based resource allocation (MoRRA) framework is proposed to optimize the allocation of resources in pandemics. The applicability of the framework is shown by the identification of high-risk areas where to prioritize the resource allocation during the current COVID-19 pandemic in Bogotá, Colombia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No additional funding was granted for writing this paper.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No medical data from external sources is used in this paper. Demographic data of Bogotá city is available on Colombian government sites.
